New research shows that genetic variations continue to accrue throughout tumor development. Having the ability to conduct deep sequencing on the healthy and cancerous cells in a patient, at multiple stages of growth and treatment, has led to invaluable findings and new directions for analyses in the field.
This course explores the role of genomics in cancer diagnosis, prognosis and treatment. Providing a greater view of mutations through tumor profiling, more targeted and personalized health care can be administered and positively impact disease outcomes. Discover the latest research advancing the study of cancer and the power of genomics in medical decision making.
This course is an elective course in the Stanford Genetics and Genomics Certificate.
You Will Learn
Assessments of hereditary risk through multi-gene panel screens
Classifications of cancers by genomic differences
Evolutions of cancer cells that cause treatment resistance
New technologies for non-invasive analyses
Spectrums and sub-types of cancer mutations
Christina Curtis, Assistant Professor of Medicine and Genetics, Stanford University
James Ford, Associate Professor of Medicine (Oncology) and of Genetics and, (By courtesy), of Pediatrics, Stanford University
Natalie Jaeger, Instructor, Stanford University
Michael Snyder, Professor and Chair in Genetics, Stanford University
Lars Steinmetz, Professor of Genetics, Stanford University
*This certificate neither substitutes for, nor leads to, being board certified as a genetic counselor (ABGC) or clinical geneticist (ABMG)